216
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Self-Management in Allergic Rhinitis: Strategies, Outcomes and Integration into Clinical Care

ORCID Icon
Pages 1087-1095 | Received 01 Jun 2023, Accepted 03 Oct 2023, Published online: 05 Oct 2023

References

  • Blöndal V, Sundbom F, Zhou X, et al. Allergic sensitisation and type-2 inflammation is associated with new-onset and persistent allergic disease. Clin Transl Allergy. 2023;13(4):e12240. doi:10.1002/clt2.12240
  • Ciprandi G, Tosca MA. Turbinate hypertrophy, allergic rhinitis, and otitis media. Curr Allergy Asthma Rep. 2021;21(9):44. doi:10.1007/s11882-021-01021-y
  • Ciprandi G, Cirillo C, Klersy C, Marseglia GL, Caimmi D, Vizzaccaro A. Nasal obstruction is the key symptom in hay fever patients. Otolaryngol Head Neck Surg. 2005;133(3):429–435. doi:10.1016/j.otohns.2005.05.049
  • Bousquet J, Anto JM, Bachert C, et al. Allergic rhinitis. Nature Rev. 2020;6:95.
  • Wheatley LM, Togias A, Solomon CG. Allergic rhinitis. N Engl J Med. 2015;372(5):456–463. doi:10.1056/NEJMcp1412282
  • Colas C, Brosa M, Anton E, et al. Estimate of the total costs of allergic rhinitis in specialized care based on real- world data: the FERIN study. Allergy. 2017;72(6):959–966. doi:10.1111/all.13099
  • Meltzer EO. Allergic rhinitis: burden of illness, quality of life, comorbidities, and control. Immunol Allergy Clin North Am. 2016;36(2):235–248. doi:10.1016/j.iac.2015.12.002
  • Zhang Y, Lan F, Zhang L. Advances and highlights in allergic rhinitis. Allergy. 2021;76(11):3383–3389. doi:10.1111/all.15044
  • Brożek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950–958. doi:10.1016/j.jaci.2017.03.050
  • Tosca MA, Licari A, Pistorio A, Marseglia GL, Ciprandi G, Marseglia GL; “ControL’Asma” Study Group. ControL’Asma Project: new insights. Pediatr Allergy Immunol. 2020;31(Suppl 26):23–25. doi:10.1111/pai.13353
  • Anto JM, Bousquet J, Akdis M, et al. Mechanisms of the Development of Allergy (MeDALL): introducing novel concepts in allergy phenotypes. J Allergy Clin Immunol. 2017;139(2):388–399. doi:10.1016/j.jaci.2016.12.940
  • Ciprandi G, Cirillo I. Monosensitization and polysensitization in allergic rhinitis. Eur J Intern Med. 2011;22(6):e75–e79. doi:10.1016/j.ejim.2011.05.009
  • Roberts G, Pfaar O, Akdis CA, et al. EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy. 2018;73(4):765–798. doi:10.1111/all.13317
  • Ciprandi G, Varricchio A, Tajana G, La Mantia I, Tommasino C. Peripheral eosinophil counts correlate with nasal eosinophil counts in patients with rhinitis. J Investig Allergol Clin Immunol. 2018;28(6):428–430. doi:10.18176/jiaci.0306
  • Scadding GK, Kariyawasam HH, Scadding G, et al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007). Clin Exp Allergy. 2017;47(7):856–889. doi:10.1111/cea.12953
  • Bousquet JJ, Schünemann HJ, Togias A, et al. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases. Clin Transl Allergy. 2019;9(1):44. doi:10.1186/s13601-019-0279-2
  • Wise SK, Damask C, Roland LT, et al. International consensus statement on allergy and rhinology: allergic rhinitis - 2023. Int Forum Allergy Rhinol. 2023;13(4):293–859.
  • Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. J Allergy Clin Immunol. 2020;146(4):721–767. doi:10.1016/j.jaci.2020.07.007
  • Bousquet J, Anto JM, Bachert C, et al. From ARIA guidelines to the digital transformation of health in rhinitis and asthma multimorbidity. Eur Resp J. 2019;54(6):1901023. doi:10.1183/13993003.01023-2019
  • Ciprandi G, Tosca MA. Nutraceuticals and non-pharmacological remedies for managing patients with allergic rhinitis. Minerva Pediatr . In press 2023.
  • Nelson HS. Future directions in allergen immunotherapy. Allergy Asthma Proc. 2022;43(4):356–362. doi:10.2500/aap.2022.43.210098
  • Kuehl BL, Abdulnour S, O’Dell M, Kyle TK. Understanding the role of the healthcare professional in patient self-management of allergic rhinitis. SAGE Open Med. 2015;3:2050312115595822. doi:10.1177/2050312115595822
  • Chodosh J, Morton SC, Mojica W. Meta-analysis: chronic disease self-management programs for older adults. Ann Intern Med. 2005;143(6):427–438. doi:10.7326/0003-4819-143-6-200509200-00007
  • World Health Organization (WHO). Global Status Report on Noncommunicable Diseases 2010. Geneva: World Health Organization; 2011.
  • Smith M, Bates DW, Bodenheimer T, Cleary PD. Why pharmacists belong in the medical home. Health Aff. 2010;29(5):906–913. doi:10.1377/hlthaff.2010.0209
  • You JH, Wong FY, Chan FW, Wong EL, Yeoh E-K. Public perception on the role of community pharmacists in self-medication and self-care in Hong Kong. BMC Clin Pharmacol. 2011;11(1):19. doi:10.1186/1472-6904-11-19
  • Carr WW, Yawn BP. Management of allergic rhinitis in the era of effective over-The-counter treatments. Postgrad Med. 2017;129(6):572–580. doi:10.1080/00325481.2017.1333384
  • Tan R, Cvetkovski B, Kritikos V, et al. Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon. Asthma Res Pract. 2017;3(1):8. doi:10.1186/s40733-017-0036-z
  • Ciprandi G, Cirillo I, Vizzaccaro A, Milanese M, Tosca MA. Nasal obstruction in patients with seasonal allergic rhinitis: relationships between allergic inflammation and nasal airflow. Int Arch Allergy Immunol. 2004;134(1):34–40. doi:10.1159/000077531
  • Cvetkovski B, Tan R, Kritikos V, et al. A patient-centric analysis to identify key influences in allergic rhinitis management. Prim Care Resp Med. 2018;28(1):34. doi:10.1038/s41533-018-0100-z
  • Tan R, Cvetkovski B, Kritikos V, et al. Management of allergic rhinitis in the community pharmacy: identifying the reasons behind medication self-selection. Pharm Pract. 2018;16:1332.
  • Ying Yap JS, Qiag Tang CW, Ling Hor HM, Ka Chong JB, Yap KZ. Process evaluation of the Community Pharmacist-Led Allergic Rhinitis Management (C-PhARM) service in Singapore. Pharmacy. 2019;7(2):56. doi:10.3390/pharmacy7020056
  • Abdullah B, Snidvongs K, Lestari Poerbonegoro N, Sutikno B. Reshaping the management of allergic rhinitis in primary care: lessons from the COVID-19 pandemic. Int J Environ Res Pub Health. 2022;19(20):13632. doi:10.3390/ijerph192013632
  • Thong HK, Wong DKC, Gendeh HS, Saim L, Athar PP, Saim A. Perception of telemedicine among medical practitioners in Malaysia during COVID-19. J Med Life. 2021;14(4):468–480. doi:10.25122/jml-2020-0119
  • Thomas I, Siew L, Rutkowski K. Synchronous telemedicine in allergy: lessons learned and transformation of care during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2021;9(1):170–176.e1. doi:10.1016/j.jaip.2020.10.013
  • Waibel KH, Bickel RA, Brown T. Outcomes from a regional synchronous tele-allergy service. J Allergy Clin Immunol Pract. 2019;7(3):1017–1021. doi:10.1016/j.jaip.2018.10.026
  • Tan R, Cvetkovski B, Kritikos R, et al. Identifying an effective mobile health application for the self-management of allergic rhinitis and asthma in Australia. J Asthma. 2019;57:1–15.
  • Thakkar J, Kurup R, Laba TL, et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med. 2016;176(3):340–349. doi:10.1001/jamainternmed.2015.7667
  • Huang X, Matricardi PM. Allergy and asthma care in the mobile phone era. Clin Rev Aller Immunol. 2019;56(2):161–173. doi:10.1007/s12016-016-8542-y
  • Baharudin A, Latiff AH, Yap F, et al. Using patient profiles to guide the choice of antihistamines in the primary care setting in Malaysia: expert consensus and recommendations. Clin Risk Manag. 2019;15:1267–1275. doi:10.2147/TCRM.S221059
  • Abdullah B, Snidvongs K, Recto M, Poerbonegoro NL, Wang DY. Primary care management of allergic rhinitis: a cross-sectional study in four ASEAN countries. Multidiscip Respir Med. 2020;16:726.
  • Bousquet J, Hellings PW, Agache I, et al. ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016;6:47. doi:10.1186/s13601-016-0137-4
  • Bourret R, Bousquet J, Mercier J, et al. MASK rhinitis, a single tool for integrated care pathways in allergic rhinitis. World Hosp Health Serv. 2015;51(3):36–39.
  • Bousquet J, Schunemann HJ, Fonseca J, et al. MACVIA-ARIA Sentinel NetworK for Allergic Rhinitis (MASK-Rhinitis): the new generation guideline implementation. Allergy. 2015;70(11):1372–1392. doi:10.1111/all.12686
  • Bousquet J, Farrell J, Crooks G, et al. Scaling up strategies of the chronic respiratory disease programme of the European innovation partnership on active and healthy ageing (Action Plan B3: area 5). Clin Transl Allergy. 2016;6(1):29. doi:10.1186/s13601-016-0116-9
  • Bousquet J, Mohammad Y, Bedbrook A, et al. Country activities of Global Alliance against Chronic Respiratory Diseases (GARD): focus presentations at the 11th GARD General Meeting, Brussels. J Thorac Dis. 2018;10(12):7064–7072. doi:10.21037/jtd.2018.12.84
  • Siroux V, Boudier A, Nadif R, Lupinek C, Valenta R, Bousquet J. Association between asthma, rhinitis, and conjunctivitis multimorbidities with molecular IgE sensitization in adults. Allergy. 2019;74(4):824–827. doi:10.1111/all.13676
  • Amaral R, Bousquet J, Pereira AM, et al. Disentangling the heterogeneity of allergic respiratory diseases by latent class analysis reveals novel phenotypes. Allergy. 2018;74(4):698–708. doi:10.1111/all.13670
  • Bousquet J, Bedbrook A, Czarlewski W, et al. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clin Transl Allergy. 2019;9(1):16. doi:10.1186/s13601-019-0252-0
  • Bousquet J, Farrell J, Illario M. Aligning the good practice MASK with the objectives of the European innovation partnership on active and healthy ageing. Allergy Asthma Immunol Res. 2020;12(2):238–258. doi:10.4168/aair.2020.12.2.238
  • Bousquet J, Addis A, Adcock I, et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J. 2014;44(2):304–323. doi:10.1183/09031936.00014614
  • Li AR, Zhang K, Reddy PD, et al. Systematic review of measures of disease severity in rhinitis. Int Forum Allergy Rhinol. 2021;11(9):1367–1377. doi:10.1002/alr.22794
  • Vieira RJ, Sousa-Pinto B, Cardoso-Fernandes A, et al. Control of Allergic Rhinitis and Asthma Test: a systematic review of measurement properties and COSMIN analysis. Clin Transl Allergy. 2022;12(9):e12194. doi:10.1002/clt2.12194
  • Pedersen CK, Haase C, Aanaes K, von Buchwald C, Backer V. An update on patient reported outcomes in type 2 inflammation airway disease. Curr Opin Allergy Clin Immunol. 2023;23(1):1–8. doi:10.1097/ACI.0000000000000873
  • Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res. 2011;63(Suppl 11):S240–S252. doi:10.1002/acr.20543
  • Karcioglu O, Topacoglu H, Dikme O, Dikme O. A systematic review of the pain scales in adults: which to use? Am J Emerg Med. 2018;36(4):707–714. doi:10.1016/j.ajem.2018.01.008
  • Sousa-Pinto B, Azevedo LF, Jutel M, et al. Development and validation of combined symptom-medication scores for allergic rhinitis. Allergy. 2022;77(7):2147–2162. doi:10.1111/all.15199
  • Ciprandi G, Mora F, Cassano M, Gallina AM, Mora R. Visual analog scale (VAS) and nasal obstruction in persistent allergic rhinitis. Otolaryngol Head Neck Surg. 2009;141(4):527–529. doi:10.1016/j.otohns.2009.06.083
  • Ciprandi G, Tosca MA, Signori A, Cirillo I. Visual analogue scale assessment of nasal obstruction might define patients candidates to spirometry. Rhinology. 2011;49(3):292–296. doi:10.4193/Rhino10.303
  • Ciprandi G, Klersy C, Ameli F, Cirillo I. Clinical assessment of a nasal decongestion test by visual analog scale in allergic rhinitis. Am J Rhinol. 2008;22(5):502–505. doi:10.2500/ajr.2008.22.3214
  • Marseglia GL, Cirillo I, Klersy C, et al. Clinical assessment of nasal decongestion test by VAS in adolescents. Pediatr Allergy Immunol. 2009;20(2):187–191. doi:10.1111/j.1399-3038.2008.00750.x
  • Ciprandi G, La Mantia I. VAS for assessing the perception of antihistamines use in allergic rhinitis. Acta Biomed. 2019;90(7–S):41–44. doi:10.23750/abm.v90i7-S.8657
  • Zhang K, Li AR, Miglani A, Nguyen SA, Schlosser RJ. Effect of medical therapy in allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2022;36(2):269–280. doi:10.1177/19458924211041438
  • Bousquet J, Arnavielhe S, Bedbrook A, et al. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clin Transl Allergy. 2018;8(1):45. doi:10.1186/s13601-018-0227-6
  • Menditto E, Costa E, Midao L, et al. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study. Clin Exp Allergy. 2019;49(4):442–460. doi:10.1111/cea.13333
  • Bedard A, Basagana X, Anto JM, et al. Mobile technology offers novel insights on control and treatment of allergic rhinitis. The MASK study. J Allergy Clin Immunol. 2019;144(1):135–143.e6. doi:10.1016/j.jaci.2019.01.053
  • Sousa-Pinto B, Sa-Sousa A, Vieira RJ, et al. Behavioural patterns in allergic rhinitis medication in Europe: a study using MASK-air((R)) real-world data. Allergy. 2022;77(9):2699–2711. doi:10.1111/all.15275
  • Vandenplas O, Suarthana E, Rifflart C, Lemiere C, Le Moual N, Bousquet J. The impact of work-related rhinitis on quality of life and work productivity: a General Workforce-Based Survey. J Allergy Clin Immunol Pract. 2020;8(5):1583–1591.e5. doi:10.1016/j.jaip.2019.12.033
  • Bousquet J, Devillier P, Arnavielhe S, et al. Treatment of allergic rhinitis using mobile technology with real-world data: the MASK observational pilot study. Allergy. 2018;73(9):1763–1774. doi:10.1111/all.13406
  • Bousquet J, Schroder-Bernhardi D, Bachert C, et al. Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on MIDAS and OTCims platforms. Clin Exp Allergy. 2021;51(8):1033–1045. doi:10.1111/cea.13884
  • Bedard A, Basagana X, Anto JM, et al. Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study. Clin Transl Allergy. 2020;10(1):62. doi:10.1186/s13601-020-00342-x
  • Sousa-Pinto B, Sa-Sousa A, Vieira RJ, et al. Cutoff values of MASK-air patient-reported outcome measures. J Allergy Clin Immunol Pract. 2023;11(4):1281–1289. doi:10.1016/j.jaip.2022.12.005
  • Mitsias DI, Dimou MV, Lakoumentas J, et al. Effect of nasal irrigation on allergic rhinitis control in children; complementarity between CARAT and MASK outcomes. Clin Transl Allergy. 2020;10(1):9. doi:10.1186/s13601-020-00313-2
  • Bhargave C, Verma M, Jakes RW, Okamoto Y. Knowledge and attitude among patients and physicians on allergic rhinitis (KAPPA): an international survey. J Asthma Allergy. 2022;15:1645–1664. doi:10.2147/JAA.S382441
  • Glattacker M, Boeker M, Anger R, et al. Evaluation of a mobile phone app for patients with pollen-related allergic rhinitis: prospective longitudinal field study. JMIR Mhealth Uhealth. 2020;8(4):e15514. doi:10.2196/15514
  • Ventura MT, Giuliano AFM, Buquicchio R, et al. Implementation of the MASK-Air® App for Rhinitis and Asthma in Older Adults: MASK@Puglia Pilot Study. Int Arch Allergy Immunol. 2022;183(1):45–50. doi:10.1159/000518032
  • Park D-Y, Lee YJ, Kim D-K, et al. KAAACI allergic rhinitis guidelines: part 2. update in non-pharmacological management. Allergy Asthma Immunol Res. 2023;15(2):145–159. doi:10.4168/aair.2023.15.2.145
  • Head K, Snidvongs K, Glew S, et al. Saline irrigation for allergic rhinitis. Cochrane Database Syst Rev. 2018;6(6):CD012597. doi:10.1002/14651858.CD012597.pub2
  • Li CL, Lin HC, Lin CY, Hsu TF. Effectiveness of hypertonic saline nasal irrigation for alleviating allergic rhinitis in children: a systematic review and meta-analysis. J Clin Med. 2019;8(1):64. doi:10.3390/jcm8010064
  • May JR, Dolen WK. Management of allergic rhinitis: a review for the community pharmacist. Clin Ther. 2017;39(12):2410–2419. doi:10.1016/j.clinthera.2017.10.006